(Case Western Reserve University) Jonathan Stamler, M.D., Director of the Institute for Transformative Molecular Medicine at the Case Western Reserve University has recently received a $4.7 million contract from the Defense Advanced Research Projects Agency to fund the development of a new class of drugs that will selectively dilate blood cells under hypoxia (lack of oxygen in the body's tissues) and thereby enhance soldiers' performance at high altitude.
Read »Navigation
User login
Visit the BiotechMashup Blog
Best upcoming scoops - Biology
- Regulation of Cyclooxygenase-2 Expression by Heat: A Novel Aspect of Heat Shock Factor 1 Function in Human Cells
- New treatment for chronic pain after spinal cord injury
- Caltech researchers develop gene therapy to boost brain repair for demyelinating diseases
- Media alert: Society of Interventional Radiology's 37th Annual Scientific Meeting
- Boston University research suggests new pathways for cancer progression